Xiao Meng Jiang

Beijing Huibao Yuan Biotechnology Co., Ltd. engages in the medical research and experimental development activities. Its business scopes include technology promotion, technical consulting, sale of food and electronic products, and import and export business. The company was founded on July 15, 2011 and is headquartered in Beijing, China.

Zhejiang Jianfeng Pharmaceutical Co., Ltd. engages in manufacture and sales of medicine and health foods. It main products include Aspartic Acid Amlodipine, Aceclofenac Sustained-release, Paroxetine Hydrochloride Tablets, drop pills, and eye drops. The company was founded on December 30, 1998 and is headquartered in Zhejiang, China.

Biocompounds Pharmaceutical, Inc. engages in the research, production, and sale of agricultural products and active pharmaceutical ingredients (API). Its products include molecular targeted medicines, alkaloids, anti-metabolic medicines, cancer medicines, venereal disease medicines, cardiovascular medicines, and anti-viral medicines. The company was founded on October 20, 2003 and is headquartered in Shanghai, China.

Tasly Holding Group Co., Ltd. engages in the pharmaceutical enterprise technology. Its business includes Traditional Chinese medicine, chemical and biological medicine, healthcare products, functional foods, and consulting services. The company was founded in 1994 and is headquartered in Tianjin, China.

Part of China National Building Material Co., Ltd., South Cement Co., Ltd. is a Chinese company that manufactures and distributes cement, concrete, and glass. The company is based in Shanghai, China. The company was founded in 2007. Jia Xiang Xiao has been the CEO of the company since 2009. South Cement Co. was acquired by Xinjiang Tianshan Cement Co., Ltd. from China National Building Material Co., Ltd. on September 28, 2021 for $7,730.59 million.